Prevalence and risk factors associated with chronic kidney disease in adults over 40 years: A population study from Central China

Nephrology

Volumn 15, Issue 3, 2010, Pages 354-361

  Shan, Yan ^a   Zhang, Qian ^b   Liu, Zhangsuo ^b   Hu, Xiaozhou ^a   Liu, Dongwei ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

China; Chronic kidney disease; Epidemiology; Screening

Indexed keywords

CREATININE; URIC ACID;

ADULT; AGE; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHINA; CHRONIC KIDNEY DISEASE; CLINICAL INDICATOR; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; HYPERTENSION; KIDNEY FUNCTION TEST; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; URIC ACID BLOOD LEVEL; URINALYSIS;

ADULT; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; AWARENESS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; CHINA; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMATURIA; HUMANS; HYPERTENSION; HYPERURICEMIA; KIDNEY; KIDNEY DISEASES; LOGISTIC MODELS; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; URBAN HEALTH;

EID: 77950475444     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01249.x     Document Type: Article

References (44)

1. Hossain MP, Goyder EC, Rigby JE, El NM. CKD and poverty: A growing global challenge. Am. J. Kidney Dis. 2009 53 : 166 174.
2. Zhang L, Zuo L, Xu G et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol. Dial. Transplant. 2007 22 (4 1093 1099.
3. Zhang L, Zhang P, Wang F et al. Prevalence and factors associated with CKD: A population study from Beijing. Am. J. Kidney Dis. 2008 51 : 373 384.
4. Chen W, Chen W, Wang H et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol. Dial. Transplant. 2009 24 : 1205 1212.
5. Xie Y, Chen X. Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. Am. J. Nephrol. 2008 28 (1 1 7.
6. Ryu S, Chang Y, Woo HY et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am. J. Kidney Dis. 2009 53 : 59 69.
7. Iseki K. Chronic kidney disease in Japan. Intern. Med. 2008 47 : 681 689.
8. Kim SY, Jin DC, Bang BK. Current status of dialytic therapy in Korea. Nephrology (Carlton) 2003 8 (Suppl S2 9.
9. Barsoum RS. Chronic kidney disease in the developing world. N. Engl. J. Med. 2006 354 : 997 999.
10. KDIGO. Kidney disease: Improving global outcomes (KDIGO). Kidney Int. Suppl. 2008 109 S1 99.
11. Neumann ME. KDIGO takes clinical practice guidelines to a global level. Nephrol. News Issues 2006 20 (12 40 41, 43, 47.
12. Ma YC, Zuo L, Chen JH et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 2006 17 (10 2937 2944.
13. Foley RN, Wang C, Ishani A et al. Kidney function and sarcopenia in the United States general population: NHANES III. Am. J. Nephrol. 2007 27 : 279 286.
14. White SL, Polkinghorne KR, Cass A et al. Alcohol consumption and 5-year onset of chronic kidney disease: The AusDiab study. Nephrol. Dial. Transplant. 2009 24 : 2464 2472.
15. Hallan SI, Ritz E, Lydersen S et al. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J. Am. Soc. Nephrol. 2009 20 : 1069 1077.
16. Schieppati A, Remuzzi G. The future of renoprotection:frustration and promises. Kidney Int. 2003 64 : 1947 1955.
17. Iseki K, Tokashiki K, Iseki C et al. Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease. Clin. Exp. Nephrol. 2008 12 : 363 369.
18. Brown WW, Peters RM, Ohmit SE et al. Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP). Am. J. Kidney. Dis. 2003 42 (1 22 35.
19. Bhuriya R, Li S, Chen SC et al. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: An analysis from the Kidney Early Evaluation Program (KEEP). Am. J. Kidney Dis. 2009 53 (4 Suppl 4 S3 10.
20. Boulware LE, Jaar BG, Tarver-Carr ME et al. Screening for proteinuria in US adults:a costt-effectiveness analysis. JAMA 2003 290 (23 3101 3114.
21. Rossert JA, Wauters JP. Recommendations for the screening and management of patients with chronic kidney disease. Nephrol. Dial. Transplant. 2002 17 (Suppl 1 19 28.
22. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007 298 : 2038 2047. (Pubitemid 350074801)
23. Snyder JJ, Foley RN, Collins AJ. Prevalence of CKD in the United States: A sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am. J. Kidney Dis. 2009 53 : 218 228.
24. Nitsch D, Felber DD, von Eckardstein A et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: Results of the Swiss SAPALDIA study. Nephrol. Dial. Transplant. 2006 21 : 935 944.
25. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J. Am. Soc. Nephrol. 2003 7 (Suppl 2 S131 8.
26. Feehally J, O'Donoghue DJ, Ballardie FW. Current nephrological practice in the investigation of haematuria: Relationship to incidence of IgA nephropathy. J. R. Coll. Physicians Lond. 1989 23 : 228 231.
27. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int. 2006 69 : 375 382.
28. Martin A, Mellotte G, O'Neill D. Chronic kidney disease in the elderly; a silent epidemic. Ir. Med. J. 2005 98 (2 46 7.
29. Garg AX, Papaioannou A, Ferko N, Campbell G, Clarke JA, Ray JG. Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int. 2004 65 (2 649 653.
30. Manjunath G, Tighiouart H, Coresh J et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003 63 (3 1121 1129. (Pubitemid 36315592)
31. Cirillo M, Laurenzi M, Mancini M, Zanchetti A, Lombardi C, De Santo NG. Low glomerular filtration in the population: Prevalence, associated disorders, and awareness. Kidney Int. 2006 70 (4 800 806.
32. Tracy RP. Inflammation, the metabolic syndrome and cardiovascular risk. Int. J. Clin. Pract. Suppl. 2003 134 10 17.
33. Smith SR. Metabolic syndrome targets. Curr. Drug Targets CNS Neurol. Disord. 2004 3 : 431 439.
34. Ninomiya T, Kiyohara Y, Kubo M et al. Metabolic syndrome and CKD in a general Japanese population: The Hisayama Study. Am. J. Kidney Dis. 2006 48 : 383 391.
35. Tozawa M, Iseki C, Tokashiki K et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens. Res. 2007 30 : 937 943.
36. Liu BC, Wu XC, Wang YL et al. Investigation of the prevalence of CKD in 13,383 Chinese hospitalised adult patients. Clin. Chim. Acta 2008 387 (1-2 128 132.
37. Zhang L, Zuo L, Wang F et al. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin. Proc. 2007 82 : 822 827.
38. Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp. Gerontol. 2008 43 : 347 352.
39. Wang ZW, Jiang T, Li JP et al. Regulation of renal lipid metabolism, lipid accumulation and glomerulosclerosis in FVBdb/db mice with 2 - Type diabetes [J]. Diabetes 2005 54 (8 2328 2335.
40. Wu Y, Huxley R, Li L et al. Prevalence, awareness, treatment, and control of hypertension in China: Data from the china national nutrition and health survey 2002. Circulation 2008 118 : 2679 2686.
41. Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann. Intern. Med. 2005 143 : 251 264.
42. Schoolwerth AC, Engelgau MM, Hostetter TH et al. Chronic kidney disease: A public health problem that needs a public health action plan. Prev. Chronic Dis. 2006 3 (2 A57.
43. Bommer J. Prevalence and socio-economic aspects of chronic kidney disease. Nephrol. Dial. Transplant. 2002 17 (Suppl 11 8 12.
44. Wang H, Zhang L, Lv J. Prevention of the progression of chronic kidney disease: Practice in China. Kidney Int. Suppl. 2005 94 S63 7.